August 2013 FDA Recall Drug by Sandoz Incorporated
D-854-2013 - Contraceptive tablets out of sequence

This Class III drug recall was voluntarily initiated by Sandoz Incorporated on August 7, 2013 for the product Drug. The FDA reported the reason for recall as contraceptive tablets out of sequence. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-854-2013

Reason for Recall
Contraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP 0.15mg/0.03mg) is voluntarily being recalled due to inactive placebo tablets incorrectly placed in Week 9, and active tablets placed in Week 13 on the blister card
Initiated
08-07-2013
Reported
08-14-2013
Quantity
8, 681 unit cartons

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Introvale (levonorgestrel and ethinyl estradiol) tablets, USP, 0.15 mg/0.03 mg, packaged in 91 day regimen per unit carton, 3 Unit Cartons x 91 tablets per box, Rx only, Manufactured by Laboratorios Leon Farma S.A., Spain for Sandoz Inc., Princeton, NJ 08540, NDC 0781-5584-36

Batch or Lot Expiration Information

Lot# Lots: LF01643C, LF01644C, Exp 7/14